Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.

Annals of surgical oncology - 1 Feb 2010

Yamasaki Makoto, Miyata Hiroshi, Fujiwara Yoshiyuki, Takiguchi Shuji, Nakajima Kiyokazu, Nishida Toshirou, Yasuda Takushi, Matsuyama Jin, Mori Masaki, Doki Yuichiro

Abstract excerpt

BACKGROUND: Response to chemotherapy and anatomical spread are significant prognostic factors in patients with esophageal squamous cell carcinoma (ESCC) treated by chemotherapy then surgery. Predicting the response to chemotherapy would allow significant optimization of cancer treatment. METHODS: Genomic mutation and protein expression of p53 were investigated retrospectively by polymerase chain reaction (PCR)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Doxorubicin

Share to Esophageal Neoplasms

Share to Fluorouracil

Share to Immunoenzyme Techniques

Share to Survival Rate

Source

Identifiers

PMID: 19941080
DOI: 10.1245/s10434-009-0851-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.PMID 19941080Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.Semantic proximity Read ↗

The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability.Semantic proximity Read ↗

Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.Semantic proximity Read ↗

Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.Semantic proximity Read ↗

Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.Semantic proximity Read ↗

Prognostic significance of the p53 mutation in esophageal cancer.Semantic proximity Read ↗

Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.Semantic proximity Read ↗

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.Semantic proximity Read ↗

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.Semantic proximity Read ↗

p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.